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It has been shown in various systems that zinc is able to antagonize the catalytic properties of the redox-active transition metals iron and
copper, although the process is still unclear. Probably, the protective effect of Zn against oxidative stress is mainly due to the induction of a
scavenger metal binding protein such as metallothionein (MT), rather than a direct action. To support this hypothesis, in this study, the effects of
Zn, Cu, Fe, Zn+Cu and Zn+Fe treatments were investigated in a fibroblast cell line corresponding to an SV40-transformed MT-1/-2 mutant
(MT−/−), and in wild type (MT+/+), by valuing metal concentrations and apoptotic and/or necrotic processes. We also investigated the synthesis
of MT and the levels of both MT-1 and MT-2 mRNAs. In MT+/+ cells, co-treatment with Zn+Fe caused a decrease in Fe content compared to
treatment with Fe alone. After Zn and Zn+Cu exposure the expression of MT-1 and MT-2 isoforms increased with a concomitant increase in MT
synthesis. Annexin V-FITC and propidium iodide staining revealed necrotic or apoptotic cells in terminal stages, especially after Fe treatments.
Immunofluorescent staining with an anti-ssDNA Mab and annexin detected a lower signal in co-treated cells compared to the single treatments in
both cell lines. The intensity and quantity of fluorescence resulting from anti-ssDNA and Annexin V staining of MT null cells was higher
compared to wild type cells. These results suggest that Zn alone does not completely exert an anti-oxidant effect against Cu and Fe toxicity, but
that induction of MT is necessary.
© 2006 Elsevier B.V. All rights reserved.Keywords: Metallothionein; Apoptosis; Heavy metals; Mouse embryo; Fibroblast1. Introduction
The presence of copper (Cu), zinc (Zn) and iron (Fe) is
essential for different physiological functions, even though
excess Cu and Fe increases free radical levels thus enhancing
the biological damage free radical mediated [1,2]. Zn can
protect cells against oxidative damage by binding to vicinal
sulphydryl groups, therefore, preventing intramolecular disul-
fide formation. It may also protect cells by inhibiting the
production of reactive oxygen species (ROS) such as hydroxyl
(SOH) or superoxide (O2S−) by transition metals [3]. This
occurs by competition between Zn and other transition metals
such as Fe and Cu for binding sites [4]. Some studies have⁎ Corresponding author. Tel.: +39 049 8276315; fax: +39 049 8276300.
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doi:10.1016/j.bbamcr.2006.01.008reported on the ability of Zn to interact with Cu and Fe,
decreasing the metal content in cells and tissues and retarding
oxidative process [5].
Furthermore, it has been suggested that free metal ions such
as Cu and Fe, which are involved in the production of free
radicals, play an important role in the regulation and induction
of apoptosis and necrosis.
It is well known that apoptosis can be regarded as a response
to cellular damage by free radicals and is distinct from necrosis
both in terms of morphology and in its mechanism of induction.
During apoptosis, the loss of phospholipid asymmetry occurs,
which results in exposure of phophatidylserine (PS) residues at
the outer plasma membrane and may serve as a trigger for
phagocytosis. The exposure of PS occurs early during apoptosis
and precedes the loss of plasma membrane integrity [6].
Apoptosis may also be detected by the exposure of PS by
allowing FICT labeled Annexin V to bind to PS, which is
exposed at the outer membrane leaflet.
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that DNA of apoptotic chromatin has increased sensitivity to
thermal denaturation. Thus, by using a gentle DNA denaturing
agent such as formamide and heating to 75 °C, DNA
denaturation can be induced only in condensed apoptotic
chromatin [7]. In fact, formamide-induced DNA denaturation
and staining with an anti-ssDNA Mab can detect condensed
apoptotic chromatin and is useful for identification of apoptotic
cells. The formamide-Mab procedure specifically stains apo-
ptotic cells and clearly distinguishes apoptosis from necrosis.
The influence of Zn on apoptosis is a well-known
phenomenon. In both, in vitro and in vivo models, Zn
supplementation prevents apoptosis induced by a variety of
agents [8]. One anti-apoptotic mechanism of Zn is its capacity
to minimize oxidative damage to cellular organelles, thereby
suppressing major signalling pathways leading to caspase
activation and apoptosis [9]. Moreover, Zn was first described
as an inhibitor of calcium magnesium-dependent endonuclease
DNA fragmentation [10]. On the contrary, other transitional
metals like Fe or Cu can cause oxidative DNA and protein
damage by radicals generated in the Fenton reaction. Further-
more, Zn is a strong inducer of metallothioneins (MTs) that are
able to bind Cu and other metals. MTs are small proteins (6000–
7000 daltons) that are rich in cysteine residues and lack both
aromatic amino acids and histidine [11]. Due to their
multifunctional roles, MTs have been proposed as a chelator
of heavy metals and excessive essential metals, and to act as
scavengers for reactive oxygen species (ROS) [12]. Their
synthesis is induced by heavy metals and several other factors.
Therefore, induction of MTs, which bind several heavy metals
with high affinity, is a common protective mechanism [13]. This
induction depends on the metal-regulatory transcription factor
(MTF-1), but the mechanism by which transcription of mt genes
is activated has not been fully understood.
In mammalian cells, two major forms are expressed, MT-1
and MT-2, and most studies have reported that cells lacking MT-
1 or MT-2 are more sensitive to a wide range of stressors, such
as oxidative stress and excess of heavy metals. Colangelo et al.
[13], in their experiments on MT+/+ cells, have shown that MT
biosynthesis is readily induced by Cd treatment, with a
concomitant decrease in sensitivity to injury by ROS. Indeed,
in an MT−/− cell line, pre-treatment with Cd did not reduce but
actually enhanced oxidative stress.
Mahboobi et al. [14] correlated the presence (MT+/+) or the
absence of MT (MT−/−) in cells pre-treated with different
concentrations of ZnCl2, CuSO4, and CdCl2 for different time
intervals to the response to a number of different anti-tumor
drugs with different mechanisms of action. However, the
antioxidant effect of Zn supplementation in relation to apoptotic
and/or necrotic processes and MT isoform gene expression has
not yet been clarified.
Herein we investigated the effects of Cu and Fe on
cytotoxicity in a fibroblast cell line corresponding to an
SV40-transformed MT-1/-2 mutant (MT−/−) and in wild type
(MT+/+) as well as the role of Zn in cellular protection. Co-
treatment in knock-out lines has the aim of clarifying the
mechanism of action of Zn and verify if it directly reduces theapoptotic damage caused by Cu and Fe, or indirectly, by
induction of MT-1 and MT-2 isoforms.
2. Materials and methods
2.1. Cell culture
The simian virus 40 (SV40) transformed mouse embryo fibroblast for MT-1
and MT-2 double nullizygous (knock-out) mice and normal mice of the same
strain were provided by Dr. John Lazo, University of Pittsburgh were grown in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v)
fetal bovine serum and antibiotics (penicillin 100 U/ml and streptomycin 100
μg/ml) at 37 °C in an atmosphere of 5% CO2.
2.2. Treatment with heavy metals
For heavy metal treatment, cells were exposed to complete medium
containing: 50 μM ZnSO4, 75 μM CuSO4, 200 μM FeSO4, 50 μM ZnSO4 plus
75 μM CuSO4 and 50 μM ZnSO4 plus 200μM FeSO4 for 24 h. These
concentrations were estimated with the MTT cell proliferation assay, which is
based on the cellular conversion of a tetrazolium salt into a formazan product
[15]. The conversion takes place only in living cells and the amount of formazan
produced is proportional to the number of living cells present (data not shown).
Higher concentrations of these metals caused evident cytotoxic effects, whereas
lower amounts were not able to induce MT. Control cells were allowed to grow
in complete medium under the same experimental conditions.
2.3. Determination of metals and MT contents
Cells were cultured as described above (2.1 and 2.2). Cells at 75%
confluency were washed twice with phosphate buffered saline (PBS) and
harvested using 0.25% trypsin in 1 mM EDTA. Cells were sedimented by
centrifugation at 180×g for 5 min, washed twice with PBS and re-suspended in
20 mM Tris–HCl buffer (pH 7.5) supplemented with 0.006 mM leupeptin, 0.5
mM phenylmethylsulphonylfluoride (PMSF) and 0.01% β-mercaptoethanol.
Then, cells were sonicated twice on ice for 30 s in a Labsonic U instrument.
Homogenates were centrifuged at 48,000×g for 50 min at 4 °C, and the resulting
supernatants were used for metal and MT quantification. Concentrations of Cu,
Zn and Fe were determined by atomic absorption spectrophotometry with an air-
acetylene flame (Perkin-Elmer mod. 4000). MT concentrations were determined
by the silver saturation method [16]. The sample values were normalized to the
total protein content, assayed by the Folin phenol reagent method [17] using
bovine serum albumin as the standard.
2.4. RNA purification
Total RNA was isolated using Trizol reagent (Invitrogen), according to the
manufacturer's instructions. Total RNA was determined by UV absorbance at
260 nm and its purity was estimated by the absorbance ratio A260/A280 nm. In
addition, RNA integrity was confirmed by ethidium bromide staining of
ribosomal RNA following gel electrophoresis.
2.5. Reverse transcription-PCR (RT-PCR) and product analysis
First-strand cDNA was synthesized with 1 μg total RNA, 50 pmol oligo
(dT)18, 10 U Improm II Reverse transcriptase and 20 U RNase inhibitor in a
final 20μl reaction mixture containing 5× reverse transcriptase buffer, 25 mM
MgCl2 and 10 mM dNTP. The reaction mixture was incubated at 25 °C for
5 min, at 42 °C for 1 h and at 70 °C for 15 min. PCR was carried out in a
50-μl reaction mixture containing 10 mM dNTP, 10 μM of each sense and
antisense primer and 2.5 U of Taq DNA polymerase, in addition to 1 μl of
cDNA. The sequence of sense and antisense primers for mouse MT-1 were
5′-tctcggaatggaccccaactg-3′ and 5′-tttacacgtggtggcagcgc-3, respectively, for
mouse MT-2 were 5′-cgatctctcgtcgatcttca-3′ and 5′-ggagaacgagtcagggttgt-3′,
respectively and for β-actin were 5′-ccagggtgtgatggtgggaatg-3′ and 5′-
cgcacgatttccctctcagctg-3′, respectively. After an initial denaturation at 94 °C
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denaturation, 30 s at 54 °C for annealing, and 30 s at 72 °C for extension
with a final extension step at 72 °C for 5 min. The PCR products were
analyzed by electrophoresis using a 2.0% (w/v) agarose gel, which wasFig. 1. Localization of apoptotic cells (arrows) using Mabs against ssDNA and co
(MT−/−) cells (B) cell lines untreated (a) and treated with Cu (b), Zn (c) Fe (d), Zn+
cells. The different letters correspond to statistically significant differences for P<0stained with ethidium bromide and visualized under UV light. The MT-1 and
MT-2 mRNA levels were determined by RT-PCR analysis followed by
densitometry scanning. All MT-1 and MT-2 RT-PCR products were
normalized to the corresponding β-actin RT-PCR.unterstained with propidium iodide in wild type (MT+/+) (A) and in MT-null
Cu (e) and Zn+Fe (f) for 24 h. ×60 objective (a–f). (C) Percentage of apoptotic
.05.
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Cells were fixed in methanol-PBS (6:1) for 24 h at −20 °C. Cells fixed were
re-suspended in 250 μl formamide and heated in a water bath at 75 °C for 10
min. Cells were placed on ice for 10 min. Subsequently, cells were washed with
2 ml of 1% FBS in PBS, re-suspended in 100 μl Mab F7-26 (dilution 1:10 in
PBS containing 5% FBS) and incubated at room temperature for 15 min. Cells
were then rinsed with PBS and stained with fluorescein-conjugated anti-mouse
IgM (dilution 1:50 in PBS containing 1% FBS) at room temperature for 15 min.
Cells were then rinsed with PBS and re-suspended in 0.5 ml of PBS containing 1
μg/ml propidium iodide. The cells were prepared as a wet-mount on glass slides.
The slides were observed under a Radiance 2000 confocal fluorescence
microscope. The total cells and fluorescent cells were counted for each field
examined (at least 10 fields per plate). The percentage of Mab-labeled cells was
calculated as the number of FITC-stained cells divided by the total number of
cells counterstained with propidium iodide. Data from at least three independent
experiments were obtained and standard errors of measurement were calculated.
2.7. Annexin-V assay
Cells were washed with PBS and incubated with annexin-V FICT for 25 min
at room temperature. Cells were then washed with binding buffer (10 mMFig. 2. Localization of apoptotic (white arrows) and necrotic (yellow arrows) cells
(MT+/+) cell line treated with Zn (A), Cu (B), Fe (C), Zn+Cu (D) and Zn+Fe (E) and
Zn+Cu (L) and Zn+Fe (M) for 24 h. ×60 objective (A–M).HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and fixed with 4%
paraformaldehyde for 5 min at 4 °C. Then, cells were counterstained with
propidium iodide (1μg/ml) for 5 min at room temperature and were observed
under a Radiance 2000 confocal fluorescence microscope.
2.8. Statistical analysis
The experiments were set up in triplicate and the analyses of each sample
were repeated at least twice. Results are reported as the mean±S.D. Statistical
analysis was performed with the Primer statistical program. Statistical
differences were calculated with one-way analysis of variance (ANOVA) with
a Student–Newman–Keuls follow-up test. Significant difference was consid-
ered when P<0.05.3. Results and discussion
In this study, we analyzed the effects of treatment with
Zn, Cu, Fe, Zn+Cu and Zn+Fe by valuing MT and metal
content (Zn, Cu and Fe), levels of both MT-1 and MT-2
mRNAs, and localization both of apoptotic and necrotic cellsby annexin-V FICT and counterstained with propidium iodide in the wild type
MT-null (MT−/−) cell lines untreated (F) and treated with Cu (G), Zn (H) Fe (I),
Table 1
Cu, Zn, Fe, and MT levels in wild type (MT+/+) and MT-null (MT−/−) cell lines
untreated (control) and treated with Cu, Zn, Fe, Zn+Cu and Zn+Fe for 24 h
Treatment MT+/+
Cu Zn Fe MT
Control 0.01±0.00*a 0.26±0.02*a 0.06±0.00*a 6.10±0.32*
Cu 75 μM 0.05±0.00○a 0.20±0.01○a 0.07±0.00○a 6.20±0.70*
Zn 50 μM 0.03±0.00‡a 0.57±0.01†a 0.05±0.01*a 9.25±1.27○
Fe 200 μM 0.01±0.00*a 0.28±0.01*a 0.47±0.03•a 6.12±0.09*
Cu 75 μM+Zn
50 μM
0.10±0.00•a 0.86±0.03‡a 0.03±0.00‡a 7.79±0.46†
Zn 50 μM+Fe
200 μM
0.03±0.00‡a 0.60±0.00•a 0.33±0.02¤a 7.34±0.08†
Treatment MT–/–
Cu Zn Fe MT
Control 0.01±0.00*a 0.27±0.01*a 0.11±0.01*b –
Cu 75 μM 0.10±0.01†b 0.28±0.01*b 0.02±0.01‡b –
Zn 50 μM 0.01±0.00*a 0.67±0.02•b 0.03±0.01‡b –
Fe 200 μM 0.01±0.00*a 0.30±0.01*b 0.52±0.07•b –
Cu 75 μM+Zn
50 μM
0.13±0.01‡b 0.32±0.00†b 0.05±0.00‡b –
Zn 50 μM+Fe
200 μM
0.01±0.00*a 0.50±0.01‡b 0.71±0.01¤b –
Values are indicated as the mean±S.D. and expressed as μg/mg total proteins.
The different symbols correspond to statistically significant differences among
the different treatment groups, whereas the various letters correspond to
statistically significant differences between the two cell lines for P<0.05.
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determining the apoptotic index by Mab against ssDNA in
MT−/− and MT+/+. A major objective was to clarify the
antioxidant role of Zn in the fibroblast cell line corresponding to
an SV40-transformed MT-1/-2 mutant that does not express mt-
1/-2 genes. It has been reported that Zn exerts its effect in an
indirect manner by stabilizing the structure of the cell
membrane and by maintaining high MT tissue concentrations
for extended periods of time [3,5]. The purpose of our study was
that to verify if Zn can exert its protective action even in absence
of MT expression. It is known that Zn has a high capacity to
induce the MT. It has been shown that both MT-1 and MT-2
isoforms are also essential for a normal wound repair in the
CNS, to reduce oxidative stress and neuronal apoptosis and
their deficiency impairs neuronal survival. In particular,
Penkowa and Hidalgo [18] examined the expression and roles
of neuroprotective MT-1 and MT-2 in the rat CNS, in
experimental autoimmune encephalomyelitis (EAE), adminis-
tered Zn-MT-2 intraperitoneally during autoimmune disease.
They demonstrated that only Zn-MT-2 and not Zn content
decreased oxidative stress. Probably, Zn used concentration
(0.35 μg/10 g body wt) was too low to induce MT synthesis
[19]. Moreover, an extracellular action of MT is also proposed
in the recovery of the CNS from injury [20]. On the other hand,
the ability of Zn in the stabilization of sulfhydryls or reduction
in the formation of SOH from H2O2 and superoxide through
the antagonism of redox-active transition metals such as Fe and
Cu has been shown in various systems [21,22]. Holme et al.
[23] report that ZnCl2 blocked the degradation of pro-caspase
and the induction of apoptosis, on contrary Lin et al. [24]
suggest that in vivo Zn-induced oxidative stress may result in
apoptosis.
3.1. Effect of co-treatment of Zn+Cu and Cu alone on wild
type and MT-null cell lines
Our recent findings showed that both Cu accumulation and
Zn supplementation increases the tissue content of MT, whereas
Zn treatment decreases MTox (oxidized-MT) in LEC rat liver.
In this context, the large amount of MT, induced by Zn and Cu,
is probably the manifestation of a defense mechanism against
Cu accumulation, while the low levels of MTox can be
considered as an index of low oxidative stress resulting in
reduced cell death [25].
Apoptotic cells were localized using Mab anti single-strand
DNA (ssDNA) and the combination of FITC-conjugated
annexin V, which preferentially binds the newly exposed PS
on apoptotic cells, and dual staining with propidium iodide
that permits the differentiation of apoptotic from necrotic cells
by confocal microscopy analysis. The exposure of PS has
been demonstrated to occur during the effector phase, pro-
bably downstream of changes in the mitochondria, as Bcl-2
inhibited the release of mitochondrial proteins and PS ex-
posure [26].
In fact our results indicate that in MT+/+ cells co-treatment
with Zn–Cu reduced both apoptotic and necrotic cells of 24%
compared to treatment with Cu alone as shown in Figs. 1 and 2.However, we also observed that in the MT−/− cells there was a
decrease of 22% in the cell death index after Zn exposure. In the
MT+/+ cells, the apoptotic index reduction in the co-treated
cells is probably in relation to the increased synthesis of MT
induced by Zn (Table 1 and Fig. 3) and its role antioxidant and
scavenger versus ROS. On the other hand, in the MT−/− cells,
the apoptotic index reduction can be in relation only with the Zn
treatment. The Zn potential regulatory roles earlier in the
apoptotic pathway have been show in some cell types. In human
premonocytic cells induced to undergo apoptosis by hydrogen
peroxide, 1 mM Zn supplementation increased the ratio of Bcl-2
to Bax, a proapoptotic protein, resulting in the inhibition of
active caspase-3 and a reduction of apoptotic cells [27]. Aiuchi
et al. [28] reported that Zn, at concentrations above 100 μM,
inhibited the processing of caspase-3 in HL-60 cells that had
been treated with geranylgeraniol. However, Perry et al. [29]
demonstrated a dose-dependent inhibition of caspase-3 cleav-
age of PARP from 30 to 100 μM zinc.
On this basis, we analyzed the metal contents in both MT+/+
and MT−/− cells. As shown in Table 1, Cu concentrations were
significantly higher in both MT+/+ and MT−/− cells treated
with Zn+Cu compared to cells treated with Cu alone (2.0 and
1.3 fold, respectively). In the MT+/+, the increase in Cu content
could be attributable to the formation of a Cu–MTcomplex. It is
well-known that Zn is a more potent inducer of MT than Cu;
however, MT has a much higher affinity for Cu than Zn,
resulting in Cu sequestration into MT. Moreover, the MT
content in Zn+Cu treated cells was significantly higher
(1.25 fold) than in Cu treated cells. The MT concentrations in
Fig. 3. Expression of metallothionein (MT) isoforms (arbitrary units) in a wild
type (MT+/+) cell line after treatment with Cu, Zn, Fe, Zn+Cu and Zn+Fe for
24 h. (A) PCR products in agarose gel electrophoresis. (B) Levels of MT-1 and
MT-2 mRNAs under various treatment conditions. The results are expressed as
the mean±S.D. The different letters correspond to statistically significant
differences for P<0.05.
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fold, respectively, higher than in control cells, whereas no
differences were observed between Cu treated cells compared to
control cell cultures (Table 1). In accordance with a large
amount of MTsynthesis, Fig. 3 shows that both MT-1 and MT-2
mRNAs were highly induced following Zn and Zn+Cu
treatments (1.6 and 1.8 fold, respectively, for MT-1, and 1.3
and 1.2 fold for MT-2 compared to control cells), which agrees
with the observed selectivity of zinc-induced MTF-1 binding to
an MRE sequence [30]. In particular, treatment of mammalian
cells with Zn in vivo promotes rapid nuclear translocation of
MTF-1 [31] and causes a dramatic increase in MTF-1 DNA
binding activity measured in vitro concomitant with the
occupancy of MREs in the MT-1 promoter in vivo and the
activation of MT-1 gene expression [32]. However, multiple
binding factors may further modify these metal-regulated
processes [33]. The increased expression of MT-1 and MT-2
mRNAs in MT+/+ cells was associated with increased
protection against Cu toxicity as well as the harmful effects of
free radicals generated by the Fenton reaction.
Jiang et al. [34] demonstrated that Zn-induced MT was able
to bind intracellular Cu, quench the redox cycling activity of
Cu, inhibit Cu-dependent oxidative stress in membrane
phospholipids, and prevent Cu dependent apoptosis in HL-60
cells. However, it is important to point out that the Cu-bound
MT is redox inactive in the absence of oxidative stress [35].
On the other hand, in MT−/− cells, the Cu increase in the co-
treated group is probably related to the increase in GSH contentand SOD activity (data not shown). In fact, Cu is present in the
catalytic site of enzyme. Moreover, the presence of free metal
with redox properties, such as Cu, may support the formation of
free radicals and, as a consequence, the induction of SOD. We
also observed that the level of Cu in MT−/− cells after both Cu
and Zn+Cu treatment was significantly higher than in MT+/+
cells (Table 1). On this basis, we postulated that Cu-MT is more
rapidly degraded by lysosomes than other biomolecules
involved in Cu accumulation. The sequestration of excess Cu
binding MT by lysosomes [36] may be of general importance
for the homeostasis of Cu in cells. In MT−/− cells, we observed
a reduction in Zn content in Zn+Cu treated cells (about 50%)
compared to cells treated with Zn alone. This reduction may be
related to competition between metals at uptake. Membrane
transporters in the mechanism of metal homeostasis are also
gaining attention and one explanation is that the presence of
large amounts of Zn and Cu and in the absence of MT such as in
MT−/− cells, the induction and synthesis of ZnT increases. On
the other hand, in wild type cells we observed an increase in the
Zn content in co-treated cells compared to cells treated with zinc
alone. Furthermore, we also observed that in MT+/+ cells
treated with Zn+Cu, the Zn content was significantly higher
with respect to that in MT−/− cells (2.7 fold). We hypothesize
that in null type cells the transcription factor, MTF-1, which
responds to changes in intracellular Zn, not mediating MT gene
induction, is involved to a greater extent in the ZnT-1 gene
transcription facilitating Zn efflux from the cytoplasm [37]. This
hypothesis must be supported by experiments on Zn transpor-
ters and on the interactions between Cu and Zn at these specific
binding sites. Genes encoding mammalian zinc transporters
have been cloned and the corresponding proteins have also been
studied [38]. For example, ZnT-2 promoters have multiple metal
response elements, as does the MT promoter, and this may
support the competition between Cu and Zn [39]. However, it is
also possible that, due to the accumulation of Cu, changes in
subcellular distribution of metals occurred, since we evaluated
the metal content only in the supernatant fraction and not in the
total homogenate.
Given the present data, we favor the hypothesis that the
protective effect of Zn against oxidative stress is mainly due to
the induction of MT, rather than a direct action, even if the role
of Zn alone in cellular protection can not be minimized.
3.2. Effect of co-treatment of Zn+Fe and Fe alone on wild type
and MT-null cell lines
It is well known that Fe is potentially deleterious as it can
induce the formation of ROS through reduction of H2O2 to
SOH
via the Fe-catalyzed Haber–Weiss reaction [40,41]. We
observed that in MT+/+ Fe-treated cell death decreased of
28% after Zn exposure. Sreedhar et al. [42] suggest that Zn
reduces the Fe-induced hydroxyl radical production by an
increase of GSH and MT levels and maintaining the sulphydryl
group stability. It has been also demonstrated that MTs are able
to protect the cells against apoptosis/necrosis induced by
oxidative stress by iron binding [43]. Probably Zn inhibits Fe-
induced hydroxyl radical generation through Fenton reaction by
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competitive inhibition of iron uptake. In fact as expected, and in
agreement with the findings of many others MT+/+ cells
exposed to Zn showed MT upregulation, as demonstrated by
silver saturation assay. This method revealed that a significant
amount of MT protein was present in MT+/+ cells treated with
Zn+Fe (1.3 fold higher than in control cells) despite the fact
that the low endogenous levels of MTs mRNAwere found using
RT-PCR analysis. It is likely that this is related to the different
induction and degradation times of ZnFe-MT with respect to
Zn-MT and ZnCu-MT. The possibility of multiple mechanisms
on fibroblast ZnFe-MT accumulation should be considered in
studies specifically examining this aspect. We also observed
that MT-2 mRNA levels in Zn+Fe treated cells was
significantly higher than MT-1mRNA (1.2 fold). This supports
the hypothesis that a particular metal could enhance the
expression of a specific isoform of MT. However, the
contribution of other factors such as MREs (metal response
elements) and/or transcription factors should be investigated in
more detail to better clarify their role.
Furthermore, we found that Zn+Fe exposure caused Zn
accumulation with concomitant decrease (about 40%) in Fe
content. The reduction of Fe content in Fe+Zn cells compared
to Fe cells could be attributed to competitive inhibition of iron
uptake by the divalent metal transporter in the presence of zinc.
Divalent metal transporter 1 (DMT1) is predominantly a Fe
transporter. However, functionally, DMT1 can mediate import
of many other divalent metal ions, including Zn [44]. However,
in both cell death assays, we observed that Zn exposure in
combination with Fe, compared Fe exposure alone, greatly
reduced both apoptotic and necrotic index. The reduction of cell
death in the presence of Zn could be due to reduction in the
oxidative stress. In fact, the SOD/GPX ratio, index of oxidative
stress, was significantly lower in the Fe+Zn treated cells than
treated Fe cells (data non shown). These results suggest that the
protection exerted by Zn during Fe-mediated cell death could be
due to both increased levels of MT and reduction of Fe content.
On the other hand, also in the mutant cells we found that cell
death index was lower (about 44%) after treatment with Fe+Zn
compared to treatment with Fe alone. These results indicate that
other mechanisms could be involve in the cell protection against
oxidative stress induced by iron. In the MT−/− cells, we did not
observe competition between two metals at level of uptake; in
fact Fe content was higher in the Fe+Zn treated cells than Fe
treated cells. Furthermore, in this cell line the MTs are not
produced. Probably the absence of MT could result in the
redistribution of zinc from one target within a cell to another so
that the amount of free Zn increase inside the cell.
The induction and inhibition of apoptosis involves signal
transduction pathways, and the response is modified by the
concentration of free intracellular divalent metal ions. Indeed,
the trace metal zinc is an essential component of many
transcription factors and signal transduction molecules that
regulate aspects of cellular metabolism, and zinc levels
influence the regulation of mitosis and apoptosis. In particular,
zinc supplementation in thymocytes inhibits apoptosis induced
by glucocorticoids and γ-irradiation, and in vivo zinc deficiencyleads to marked thymic atrophy (acrodermatitis enteropathica)
and immunodeficiency [9]. Pre-treatment with Zn may induce
cytoprotective pathways that reduce susceptibility to apoptosis.
Thus, it seems possible that sufficiently lowering zinc
concentrations in the cytosol may directly release the inhibition
of caspases by zinc [45].
We also observed that in mutant cell line Zn seems to be a
more efficient inhibitor of Fe-induced cell death relative to Cu-
induced cell loss. In fact, the cell death Fe- and Cu-induced was
lower of 44% and 22%, respectively. This response could be
correlated to Zn different content in the two groups. We found
that the Zn content was about 1.5 fold higher in the cells treated
with Zn+Fe compared cells treated Zn+Cu.
However, we observed that the apoptotic index in MT−/−
cells was significantly increased compared to that observed in
MT+/+ cells under all treatment conditions (Fig. 1). It is also
interesting to point out that in MT+/+ cells co-treatment reduced
both apoptotic and necrotic cells compared to treatment with Fe
alone as shown in Figs. 1 and 2 (40% for Zn+Fe compared to
Fe). Moreover, previous reports have indicated that Zn has a key
role in the regulation of apoptosis in a number of cell types [46].
Indirect evidence for additional sites for Zn regulation include
the dependence of zinc-finger transcription factors that control
the expression of cellular genes involved in apoptosis, such as
nuclear factor-κB [47]. In conclusion, Zn most likely has
multiple regulatory roles in protecting cells from apoptosis.
Further studies are necessary in order to elucidate the specific
regulatory mechanisms underlying zinc protection against
apoptosis in many cell types. On this basis we believe that Zn
alone could be able to reduce in part oxidative damage, but that
concomitant action of MT and Zn alone play key role in the
protection against Fe toxicity as well as the harmful effects of
free radicals generated by the Fenton reaction.
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